Praxis Precision Medicines stock has experienced a significant surge, with some outlets reporting a 27% increase and a 6-day winning streak, while others suggest an even larger pre-market gain of 69%. The stock has reached a 3-year high, although the reason for the surge is not clear. Meanwhile, other stocks and the broader market are experiencing a selloff due to geopolitical and recession concerns, but it is unclear how this affects Praxis Precision Medicines.